Cargando…

Functional and structural characterization of axonal opioid receptors as targets for analgesia

BACKGROUND: Opioids are the gold standard for the treatment of acute pain despite serious side effects in the central and enteric nervous system. µ-opioid receptors (MOPs) are expressed and functional at the terminals of sensory axons, when activated by exogenous or endogenous ligands. However, the...

Descripción completa

Detalles Bibliográficos
Autores principales: Mambretti, Egle M, Kistner, Katrin, Mayer, Stefanie, Massotte, Dominique, Kieffer, Brigitte L, Hoffmann, Carsten, Reeh, Peter W, Brack, Alexander, Asan, Esther, Rittner, Heike L
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4994859/
https://www.ncbi.nlm.nih.gov/pubmed/27030709
http://dx.doi.org/10.1177/1744806916628734
_version_ 1782449382559318016
author Mambretti, Egle M
Kistner, Katrin
Mayer, Stefanie
Massotte, Dominique
Kieffer, Brigitte L
Hoffmann, Carsten
Reeh, Peter W
Brack, Alexander
Asan, Esther
Rittner, Heike L
author_facet Mambretti, Egle M
Kistner, Katrin
Mayer, Stefanie
Massotte, Dominique
Kieffer, Brigitte L
Hoffmann, Carsten
Reeh, Peter W
Brack, Alexander
Asan, Esther
Rittner, Heike L
author_sort Mambretti, Egle M
collection PubMed
description BACKGROUND: Opioids are the gold standard for the treatment of acute pain despite serious side effects in the central and enteric nervous system. µ-opioid receptors (MOPs) are expressed and functional at the terminals of sensory axons, when activated by exogenous or endogenous ligands. However, the presence and function of MOP along nociceptive axons remains controversial particularly in naïve animals. Here, we characterized axonal MOPs by immunofluorescence, ultrastructural, and functional analyses. Furthermore, we evaluated hypertonic saline as a possible enhancer of opioid receptor function. RESULTS: Comparative immunolabeling showed that, among several tested antibodies, which all provided specific MOP detection in the rat central nervous system (CNS), only one monoclonal MOP-antibody yielded specificity and reproducibility for MOP detection in the rat peripheral nervous system including the sciatic nerve. Double immunolabeling documented that MOP immunoreactivity was confined to calcitonin gene-related peptide (CGRP) positive fibers and fiber bundles. Almost identical labeling and double labeling patterns were found using mcherry-immunolabeling on sciatic nerves of mice producing a MOP-mcherry fusion protein (MOP-mcherry knock-in mice). Preembedding immunogold electron microscopy on MOP-mcherry knock-in sciatic nerves indicated presence of MOP in cytoplasm and at membranes of unmyelinated axons. Application of [D-Ala(2), N-MePhe(4), Gly-ol]-enkephalin (DAMGO) or fentanyl dose-dependently inhibited depolarization-induced CGRP release from rat sciatic nerve axons ex vivo, which was blocked by naloxone. When the lipophilic opioid fentanyl was applied perisciatically in naïve Wistar rats, mechanical nociceptive thresholds increased. Subthreshold doses of fentanyl or the hydrophilic opioid DAMGO were only effective if injected together with hypertonic saline. In vitro, using β-arrestin-2/MOP double-transfected human embryonic kidney cells, DAMGO as well as fentanyl lead to a recruitment of β-arrestin-2 to the membrane followed by a β-arrestin-2 reappearance in the cytosol and MOP internalization. Pretreatment with hypertonic saline prevented MOP internalization. CONCLUSION: MOPs are present and functional in the axonal membrane from naïve animals. Hypertonic saline acutely decreases ligand-induced internalization of MOP and thereby might improve MOP function. Further studies should explore potential clinical applications of opioids together with enhancers for regional analgesia.
format Online
Article
Text
id pubmed-4994859
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher SAGE Publications
record_format MEDLINE/PubMed
spelling pubmed-49948592016-09-07 Functional and structural characterization of axonal opioid receptors as targets for analgesia Mambretti, Egle M Kistner, Katrin Mayer, Stefanie Massotte, Dominique Kieffer, Brigitte L Hoffmann, Carsten Reeh, Peter W Brack, Alexander Asan, Esther Rittner, Heike L Mol Pain Original Article BACKGROUND: Opioids are the gold standard for the treatment of acute pain despite serious side effects in the central and enteric nervous system. µ-opioid receptors (MOPs) are expressed and functional at the terminals of sensory axons, when activated by exogenous or endogenous ligands. However, the presence and function of MOP along nociceptive axons remains controversial particularly in naïve animals. Here, we characterized axonal MOPs by immunofluorescence, ultrastructural, and functional analyses. Furthermore, we evaluated hypertonic saline as a possible enhancer of opioid receptor function. RESULTS: Comparative immunolabeling showed that, among several tested antibodies, which all provided specific MOP detection in the rat central nervous system (CNS), only one monoclonal MOP-antibody yielded specificity and reproducibility for MOP detection in the rat peripheral nervous system including the sciatic nerve. Double immunolabeling documented that MOP immunoreactivity was confined to calcitonin gene-related peptide (CGRP) positive fibers and fiber bundles. Almost identical labeling and double labeling patterns were found using mcherry-immunolabeling on sciatic nerves of mice producing a MOP-mcherry fusion protein (MOP-mcherry knock-in mice). Preembedding immunogold electron microscopy on MOP-mcherry knock-in sciatic nerves indicated presence of MOP in cytoplasm and at membranes of unmyelinated axons. Application of [D-Ala(2), N-MePhe(4), Gly-ol]-enkephalin (DAMGO) or fentanyl dose-dependently inhibited depolarization-induced CGRP release from rat sciatic nerve axons ex vivo, which was blocked by naloxone. When the lipophilic opioid fentanyl was applied perisciatically in naïve Wistar rats, mechanical nociceptive thresholds increased. Subthreshold doses of fentanyl or the hydrophilic opioid DAMGO were only effective if injected together with hypertonic saline. In vitro, using β-arrestin-2/MOP double-transfected human embryonic kidney cells, DAMGO as well as fentanyl lead to a recruitment of β-arrestin-2 to the membrane followed by a β-arrestin-2 reappearance in the cytosol and MOP internalization. Pretreatment with hypertonic saline prevented MOP internalization. CONCLUSION: MOPs are present and functional in the axonal membrane from naïve animals. Hypertonic saline acutely decreases ligand-induced internalization of MOP and thereby might improve MOP function. Further studies should explore potential clinical applications of opioids together with enhancers for regional analgesia. SAGE Publications 2016-02-18 /pmc/articles/PMC4994859/ /pubmed/27030709 http://dx.doi.org/10.1177/1744806916628734 Text en © The Author(s) 2016 http://creativecommons.org/licenses/by-nc/3.0/ This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 3.0 License (http://www.creativecommons.org/licenses/by-nc/3.0/) which permits non-commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access page(https://us.sagepub.com/en-us/nam/open-access-at-sage).
spellingShingle Original Article
Mambretti, Egle M
Kistner, Katrin
Mayer, Stefanie
Massotte, Dominique
Kieffer, Brigitte L
Hoffmann, Carsten
Reeh, Peter W
Brack, Alexander
Asan, Esther
Rittner, Heike L
Functional and structural characterization of axonal opioid receptors as targets for analgesia
title Functional and structural characterization of axonal opioid receptors as targets for analgesia
title_full Functional and structural characterization of axonal opioid receptors as targets for analgesia
title_fullStr Functional and structural characterization of axonal opioid receptors as targets for analgesia
title_full_unstemmed Functional and structural characterization of axonal opioid receptors as targets for analgesia
title_short Functional and structural characterization of axonal opioid receptors as targets for analgesia
title_sort functional and structural characterization of axonal opioid receptors as targets for analgesia
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4994859/
https://www.ncbi.nlm.nih.gov/pubmed/27030709
http://dx.doi.org/10.1177/1744806916628734
work_keys_str_mv AT mambrettieglem functionalandstructuralcharacterizationofaxonalopioidreceptorsastargetsforanalgesia
AT kistnerkatrin functionalandstructuralcharacterizationofaxonalopioidreceptorsastargetsforanalgesia
AT mayerstefanie functionalandstructuralcharacterizationofaxonalopioidreceptorsastargetsforanalgesia
AT massottedominique functionalandstructuralcharacterizationofaxonalopioidreceptorsastargetsforanalgesia
AT kiefferbrigittel functionalandstructuralcharacterizationofaxonalopioidreceptorsastargetsforanalgesia
AT hoffmanncarsten functionalandstructuralcharacterizationofaxonalopioidreceptorsastargetsforanalgesia
AT reehpeterw functionalandstructuralcharacterizationofaxonalopioidreceptorsastargetsforanalgesia
AT brackalexander functionalandstructuralcharacterizationofaxonalopioidreceptorsastargetsforanalgesia
AT asanesther functionalandstructuralcharacterizationofaxonalopioidreceptorsastargetsforanalgesia
AT rittnerheikel functionalandstructuralcharacterizationofaxonalopioidreceptorsastargetsforanalgesia